Cargando…
Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users
OBJECTIVES: To investigate the impact of harm-reduction programmes on HIV and hepatitis C virus (HCV) incidence among ever-injecting drug users (DU) from the Amsterdam Cohort Studies (ACS). METHODS: The association between use of harm reduction and seroconversion for human immunodeficiency virus (HI...
Autores principales: | Van Den Berg, Charlotte, Smit, Colette, Van Brussel, Giel, Coutinho, Roel, Prins, Maria |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040242/ https://www.ncbi.nlm.nih.gov/pubmed/17697278 http://dx.doi.org/10.1111/j.1360-0443.2007.01912.x |
Ejemplares similares
-
Lessons learned from the Amsterdam Cohort Studies among people who use drugs: a historical perspective
por: van Santen, Daniela K., et al.
Publicado: (2021) -
Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies
por: van den Berg, C H S B, et al.
Publicado: (2009) -
Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users
por: van den Berg, Charlotte H. S. B., et al.
Publicado: (2007) -
Drug Users in Amsterdam: Are They Still at Risk for HIV?
por: van der Knaap, Nienke, et al.
Publicado: (2013) -
Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population
por: van Rijckevorsel, Gini GC, et al.
Publicado: (2012)